US Inhaler Market Share 2019 Growth Challenges, Opportunities and Future Trends 2025
US inhaler market is anticipated to grow at a substantial rate of 1.3% during the forecast period. The growth of the market of inhaler devices in the US is mainly driven by factors which include the growing prevalence of chronic diseases such as asthma, diabetes, respiratory lung diseases and so on. Asthma is chronic inflammation of the lung airways that causes breathlessness and coughing. The number of people with asthma grows every year in the US. According to CDC, there are around 26 million asthma patients in the US, among which, nearly 18.9 million are adults and 7.1 million are children. Moreover, the prevalence of asthma in children is nearly 9.4% which is higher than that of adults accounting to around 7.7%, and higher in females nearly 9.2% than in males accounting to 7% of total asthma patients. This is one of the primary reasons for the high growth rate of the market within the country.
To Request a Sample of our Report on US
Inhaler Market: https://www.omrglobal.com/request-sample/us-inhaler-market
The US inhaler market is segmented
on the basis of device, type, application, and end-user. On the basis of
device, the market is sub-segmented into metered dosed inhaler, dry powdered
inhaler, and nebulizer. The dry powder inhaler is estimated to have largest
market share in the US inhaler market due to providing easy inhalation
solution. Whereas, the market for metered dose inhaler is estimated to be the
fastest growing at a CAGR during the forecast period owing to innovations and
collaborations by the companies for the development of metered dosed inhaler.
Based on the type, preventive, reliever, and long acting bronchodilators
inhaler are analyzed. Moreover, on the basis of application, the market has
been classified into asthma and COPD diseases. In addition, based on the
end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of US Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/us-inhaler-market
US Inhaler Market Segmentation
By Device
·
Metered Dose Inhaler
·
Dry Powder Inhaler
·
Nebulizer
By Type
·
Preventive Inhaler
·
Reliever Inhaler
·
Long Acting Bronchodilators Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
Drive Devilbiss Healthcare LLC
·
GlaxoSmithKline PLC
·
Koninklijke Philips N.V.
·
Manta Devices LLC
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries
are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment